Details

Autor(en) / Beteiligte

• Etsassala, Ninon G E R
• Ndjoubi, Kadidiatou O
• Mbira, Thilly J
• Pearce, Brendon
• Pearce, Keenau
• Iwuoha, Emmanuel I
• Hussein, Ahmed A
• Benjeddou, Mongi

Titel

Glucose-Uptake Activity and Cytotoxicity of Diterpenes and Triterpenes Isolated from Lamiaceae Plant Species

Ist Teil von

• Molecules (Basel, Switzerland), 2020-09, Vol.25 (18), p.4129

Ort / Verlag

Switzerland: MDPI AG

Erscheinungsjahr

2020

Quelle

Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals

Beschreibungen/Notizen

• The prevalence of diabetes mellitus (DM), considered one of the most common metabolic disorders, has dramatically increased and resulted in higher rates of morbidity and mortality around the world in the past decade. It is well known that insulin resistance in target tissues and a deficiency in insulin secretion from pancreatic β-cells are the main characteristics of type 2 diabetes. The aim of this study was the bio-evaluation of compounds isolated from three selected plant species: namely, , , and , for their glucose-uptake ability. Methanolic extracts were produced from the aerial parts of each plant. Compounds were identified using different spectroscopic techniques. The glucose-uptake ability of each compound was then evaluated in mammalian cells using 2-deoxyglucose-6-phosphate. The cytotoxicity of each compound was established via the MTT assay. Chromatographic purification of the three plant species yielded sixteen pure terpenoids. Compounds ( = 0.0031), ( = 0.0053), and ( = 0.0086) showed a marked increase in glucose uptake, respectively. Additionally, , , and exhibited cytotoxicity toward mammalian tissue with a decrease in cell viability of ~70%, ~68%, and ~67%, respectively. The results suggested that several compounds demonstrated a marked increase in glucose uptake, while two of the compounds exhibited signs of cytotoxicity. It may, therefore, be suggested that these compounds be considered as potential candidates for novel plant-derived alternative therapies in the treatment of type 2 diabetes.